ENvue Medical, Inc.
FEED
$0.81
-$0.02-2.01%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 2.18M | 2.55M | 2.69M | 2.34M | 2.66M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.18M | 2.55M | 2.69M | 2.34M | 2.66M |
| Cost of Revenue | 2.45M | 2.40M | 1.88M | 1.59M | 1.45M |
| Gross Profit | -271.00K | 153.00K | 806.00K | 750.00K | 1.21M |
| SG&A Expenses | 11.62M | 10.13M | 8.18M | 6.82M | 4.76M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 15.78M | 14.29M | 12.13M | 10.51M | 7.53M |
| Operating Income | -13.59M | -11.74M | -9.45M | -8.17M | -4.87M |
| Income Before Tax | -20.42M | -18.49M | -6.65M | -8.19M | -4.96M |
| Income Tax Expenses | -289.00K | -307.00K | 117.00K | 85.00K | 27.00K |
| Earnings from Continuing Operations | -20.14 | -18.19 | -6.76 | -8.27 | -4.99 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -20.14M | -18.19M | -6.76M | -8.27M | -4.99M |
| EBIT | -13.59M | -11.74M | -9.45M | -8.17M | -4.87M |
| EBITDA | -12.50M | -10.84M | -8.81M | -7.79M | -4.85M |
| EPS Basic | -21.19 | -44.21 | -69.60 | -72.25 | -98.40 |
| Normalized Basic EPS | -6.56 | -24.38 | -46.68 | -49.30 | -61.16 |
| EPS Diluted | -21.19 | -44.21 | -69.60 | -72.25 | -98.40 |
| Normalized Diluted EPS | -6.56 | -24.38 | -46.68 | -49.30 | -61.16 |
| Average Basic Shares Outstanding | 5.73M | 2.51M | 1.44M | 865.40K | 406.10K |
| Average Diluted Shares Outstanding | 5.73M | 2.51M | 1.44M | 865.40K | 406.10K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |